Identification of AAV serotypes for lung gene therapy in human embryonic stem cell-derived lung organoids
<jats:title>Abstract</jats:title> <jats:p>Gene therapy is being investigated for a range of serious lung diseases, such as cystic fibrosis and emphysema. Recombinant adeno-associated virus (rAAV) is a well-established, safe, viral vector for gene de...
Main Authors: | Meyer-Berg, H, Zhou Yang, L, Pilar de Lucas, M, Zambrano, A, Hyde, SC, Gill, DR |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2020
|
Similar Items
-
Identification of AAV serotypes for lung gene therapy in human embryonic stem cell-derived lung organoids
by: Helena Meyer-Berg, et al.
Published: (2020-10-01) -
Generation of human embryonic stem cell-derived lung organoids
by: Le Han, et al.
Published: (2022-06-01) -
Gene therapy for surfactant protein B deficiency using recombinant AAV
by: Meyer-Berg, H, et al.
Published: (2019) -
Lung adeno-squamous carcinoma modeling using oncogenic KRAS activation in human embryonic stem cell-derived alveolar organoids
by: Jianqi Feng, et al.
Published: (2023-01-01) -
In vitro generation of human pluripotent stem cell derived lung organoids
by: Briana R Dye, et al.
Published: (2015-03-01)